OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the comparative efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) agents and their biosimilars for people with neovascular age-related macular degeneration (nAMD), and provide a relative ranking of interventions using network meta-analysis (NMA) methods, considering differences in treatment intensity.

Anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD): a network meta-analysis / Lucenteforte, E., Ng, S.M., Saulle, R., Hoad, G., Schillinger, R., Virgili, G.. - In: COCHRANE LIBRARY. - ISSN 1465-1858. - ELETTRONICO. - 2026:(2026), pp. 0-0. [10.1002/14651858.cd016298]

Anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD): a network meta-analysis

Lucenteforte, Ersilia;Virgili, Gianni
2026

Abstract

OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the comparative efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) agents and their biosimilars for people with neovascular age-related macular degeneration (nAMD), and provide a relative ranking of interventions using network meta-analysis (NMA) methods, considering differences in treatment intensity.
2026
2026
0
0
Lucenteforte, Ersilia; Ng, Sueko M; Saulle, Rosella; Hoad, Geraldine; Schillinger, Robert; Virgili, Gianni
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1499937
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact